NuGen Medical Devices Inc.
NGMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,609 | $12,352 | $9,774 | $15,920 |
| - Cash | $4,293 | $5,424 | $6,187 | $6,946 |
| + Debt | $18,316 | $17,436 | $15,816 | $17,804 |
| Enterprise Value | $26,632 | $24,364 | $19,404 | $26,778 |
| Revenue | $35 | $22 | $117 | $416 |
| % Growth | 56.8% | -81.1% | -71.9% | – |
| Gross Profit | $21 | $13 | $65 | $225 |
| % Margin | 60.9% | 60.2% | 55.3% | 54.1% |
| EBITDA | -$901 | -$1,422 | $2,398 | $1,380 |
| % Margin | -2,598.1% | -6,429.5% | 2,051.9% | 332% |
| Net Income | -$1,867 | -$2,327 | $1,566 | $510 |
| % Margin | -5,383.1% | -10,520.5% | 1,339.5% | 122.7% |
| EPS Diluted | -0.008 | -0.01 | 0.007 | 0.002 |
| % Growth | 21.6% | -247.8% | 200% | – |
| Operating Cash Flow | -$1,054 | -$710 | -$820 | -$2,792 |
| Capital Expenditures | -$75 | -$53 | $0 | -$10 |
| Free Cash Flow | -$1,130 | -$763 | -$820 | -$2,803 |